Background. Although radical cystectomy (RC) is the clinical practice guideline-recommended treatment of muscle-invasive bladder cancer (MIBC), bladder-sparing trimodality therapy (TMT) has emerged as a valid treatment option. Findings comparing the survival outcomes for MIBC patients who underwent RC and TMT are inconclusive. Objective. We designed a large hospital-based multicohort study to compare the effectiveness of TMT with RC. Methods. Information on deaths was jointly retrieved from EMR (electronic medical record), cause of death registry, and chronic disease surveillance as well as study-specific questionnaire. To avoid the systematical difference between patients who received two modalities, RC-MIBC cohort was propensity score-matched to TMT-MIBC cohort, and the Cox proportional hazard regression was used to calculate the overall survival (OS) and disease-specific survival (DSS). Results. There were 891 MIBC patients treated with RC and another 891 MIBC patients who underwent with TMT in the propensity score matching. Comparable effectiveness between two modalities was observed for DSS (HR, 1.20; 95 confidence interval (CI), 0.94 to 1.49) and OS (HR, 1.17; 95 CI, 0.91 to 1.43) according to multiple adjustment after a median follow-up of approximately 9.3 years. However, a relatively higher mortality rate around 5 years after TMT treatment was found compared to RC (HR, 1.26; 95 CI, 1.01 to 1.53). The respective 5-year OS rates were 69 and 73 for TMT cohort and RC cohort, respectively. Conclusions. Our findings supported that MIBC patients with TMT yielded survival outcomes comparable to MIBC patients who underwent RC overall. Treatment options should be suggested considering patients age and willingness.
2 March 2023 in European Journal of Clinical Investigation
Background: Depression and antidepressant use have been suggested to be associated with tuberculosis sequelae, but whether these associations are causal remains unclear. We aimed to investigate the potential associations of genetically predicted depression and antidepressant use with the risk of tuberculosis sequelae using a two-sample Mendelian randomization (MR) study. Methods: Summary statistics for depression (13,559 cases and 435,855 controls), antidepressant use (33,757 cases and 270,405 controls), and tuberculosis sequelae (727 cases and 497,160 controls) were extracted from large-scale genome-wide association studies of European-ancestry participants. MR estimates were generated using the inverse-variance weighted (IVW) method in the main analysis with a series of sensitivity analyses. Results: In the primary fixed-effects IVW analysis, genetically predicted depression showed suggestive evidence of an association with an increased risk of tuberculosis sequelae (OR = 1.218, 95% CI: 1.003–1.480, p = 0.047), whereas genetically predicted antidepressant use showed suggestive evidence of an inverse association with the risk of tuberculosis sequelae (OR = 0.692, 95% CI: 0.497–0.964, p = 0.029). Both primary estimates provided suggestive evidence of associations, although they did not meet the Bonferroni-corrected significance threshold of p < 0.025. In the multiplicative random-effects IVW sensitivity analyses, the effect directions remained unchanged although statistical significance was not retained, while other complementary sensitivity analyses generally yielded directionally consistent estimates. Conclusions: Our findings provide novel, hypothesis-generating genetic evidence that genetically predicted depression and antidepressant use may be associated with the risk of tuberculosis sequelae. These findings highlight potentially important links between mental health-related factors and long-term tuberculosis outcomes and warrant further validation in independent studies.